These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11130222)

  • 21. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
    Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
    Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCV and HIV: a tale of two viruses.
    Sherman KE
    Rev Gastroenterol Disord; 2004; 4 Suppl 1():S48-54. PubMed ID: 15185718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between HIV-1 and HCV infections: towards a new entity?
    Winnock M; Salmon-Céron D; Dabis F; Chêne G
    J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
    Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
    PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    MacBrayne CE; Kiser JJ
    Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S12-23. PubMed ID: 27363437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
    Bräu N
    J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hepatitis C in HIV-coinfected patients.
    Hughes CA; Shafran SD
    Ann Pharmacother; 2006 Mar; 40(3):479-89; quiz 582-3. PubMed ID: 16507622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients].
    Francisci D; Valente M; Di Candilo F; Sfara C; Conte ME; Canovari B; Baldelli F; Stagni G
    Recenti Prog Med; 2004 Nov; 95(11):521-4. PubMed ID: 15598089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C in the HIV-Infected Person.
    Sulkowski MS; Thomas DL
    Ann Intern Med; 2003 Feb; 138(3):197-207. PubMed ID: 12558359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C in the HIV-infected patient.
    Sulkowski MS; Thomas DL
    Clin Liver Dis; 2003 Feb; 7(1):179-94. PubMed ID: 12691466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic issues in HIV/HCV-coinfected patients.
    Sulkowski MS; Benhamou Y
    J Viral Hepat; 2007 Jun; 14(6):371-86. PubMed ID: 17501757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of end-stage liver disease in HIV/hepatitis C virus co-infection.
    Spengler U
    Curr Opin HIV AIDS; 2011 Nov; 6(6):527-33. PubMed ID: 21918437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coinfection with HIV and hepatitis C virus in injection drug users and minority populations.
    Strader DB
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S7-13. PubMed ID: 16265618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.
    Schulze Zur Wiesch J; Pieper D; Stahmer I; Eiermann T; Buggisch P; Lohse A; Hauber J; van Lunzen J
    Clin Infect Dis; 2009 Aug; 49(3):466-72. PubMed ID: 19580412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
    Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
    J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States.
    Chen PH; Yenokyan K; Fojo AT; Hutton HE; Lesko CR; McCaul ME; Yang C; Cachay ER; Crane HM; Jacobson JM; Kim HN; Kitahata MM; Mayer KH; Moore RD; Napravnik S; Saag M; Lau B; Chander G
    Drug Alcohol Depend; 2022 Dec; 241():109673. PubMed ID: 36332596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.
    Eslam M; López-Cortés LF; Romero-Gomez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):553-8. PubMed ID: 21934619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.
    Sulkowski MS; Mast EE; Seeff LB; Thomas DL
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S77-84. PubMed ID: 10770916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.